University Medical Centre Mannheim at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

University Medical Centre Mannheim takes part in 3 sessions at ESMO 2026 in Madrid. Its sessions cover liquid biopsies in advanced lung cancer and differences between men and women in how they respond to immunotherapy. It also introduces desmoid tumours, a rare disease, with the guidelines and therapies used to manage them.

OrganizationESMO 2026 Attendance
Cancer centre & hospital
Teaching hospital of Heidelberg University's medical faculty in Mannheim, Germany.
Chair
Fri Oct 23
13:30–14:15
Talk
Sun Oct 25
15:45–16:05
Gender differences in response to immuno-oncology therapies
Toxicities of immunotherapies beyond immune checkpoints
Nursing & supportive care
Satellite
Mon Oct 26
13:00–14:30
Merck Healthcare KGaA - CARE FOR RARE: Desmoid Tumours in Clinical Practice − Shifting Strategies & Evolving Perspectives
with Hospital de la Santa Creu i Sant Pau
Sarcoma, CNS, head & neck and rare cancers
Satellite
Mon Oct 26
13:05–13:25
Introducing desmoid tumours (DTs): Disease, guidelines & therapy
Merck Healthcare KGaA - CARE FOR RARE: Desmoid Tumours in Clinical Practice − Shifting Strategies & Evolving Perspectives
Sarcoma, CNS, head & neck and rare cancers

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from University Medical Centre Mannheim

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction